Monogram Technologies Inc. (MGRM)
NASDAQ: MGRM · Real-Time Price · USD
5.80
+0.02 (0.35%)
Aug 29, 2025, 4:00 PM - Market closed

Company Description

Monogram Technologies Inc. engages in developing surgical robot to enable placement of patient optimized orthopedic implants in the United States.

It intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.

The company was formerly known as Monogram Orthopaedics, Inc. and changed its name to Monogram Technologies Inc. in May 2024.

Monogram Technologies Inc. was founded in 2015 and is headquartered in Austin, Texas.

Monogram Technologies Inc.
Monogram Technologies logo
CountryUnited States
Founded2016
IndustryMedical Devices
SectorHealthcare
Employees27
CEOBenjamin Sexson

Contact Details

Address:
3913 Todd Lane, Suite 307
Austin, Texas 78744
United States
Phone512 399 2656
Websitemonogramtechnologies.com

Stock Details

Ticker SymbolMGRM
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001769759
CUSIP Number609786108
ISIN NumberUS6097861081
Employer ID81-2349540
SIC Code3841

Key Executives

NamePosition
Benjamin Sexson C.F.A.Chairman of the Board, President and Chief Executive Officer
Dr. Douglas UnisFounder, Chief Medical Officer and Director
Dr. Kamran Shamaei Ph.D.Chief Technology Officer
Chris TysonExecutive Vice President - MZ North America

Latest SEC Filings

DateTypeTitle
Aug 29, 2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material
Aug 29, 20258-KCurrent Report
Aug 28, 2025DEFM14AFiling
Aug 28, 2025PRER14AFiling
Aug 28, 2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material
Aug 28, 20258-KCurrent Report
Aug 15, 202510-QQuarterly Report
Aug 15, 2025NT 10-QNotification of inability to timely file Form 10-Q or 10-QSB
Aug 11, 2025PREM14AFiling
Jul 31, 2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material